Discovery and Evaluation of 4-(2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyridin-2(1<i>H</i>)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor ActivityUpender Velaparthi, Dolatrai M. Vyas, Praveen Balimane et al.|Journal of Medicinal Chemistry|2008Cited by 33
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitorsKurt Zimmermann, Dolatrai M. Vyas, Mark D. Wittman et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 25
An Insulin-Like Growth Factor 1 Receptor Inhibitor Induces CYP3A4 Expression through a Pregnane X Receptor-Independent, Noncanonical Constitutive Androstane Receptor-Related MechanismLinhao Li, Hongbing Wang, Michael Sinz et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 19